Aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage

by Parc Científic de Barcelona (PCB)

With this operation, Aptadel Therapeutics begins a new stage of expansion to drive forward development of its pioneering treatment for Ewing’s sarcoma. The company is preparing a Series A funding ro...

Read more

Aptadel Therapeutics launches with a $2.1M in seed financing

by Professional Newco

Aptadel Therapeutics, a pre-clinical biomedical company focused on developing a RNA-based platform of targeted therapy delivery to treat cancer, has announced the closing of a $2.1M in seed financing....

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

SICC Innvierte, a vehicle managed by CDT...

by CDTI Innovación

With a target size of €250 million, the fund aims to complete betwee...

Photos Stream